NKT-01

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

gusperimusgusperimus trihydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Phase I study of NKT-01
A phase I study of NKT-01 (deoxyspergualin), which is a derivative of an antitumor antibiotic, spergualin, was performed by a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 2
Is this relevant?
1991
1991
Antitumor spectrum of deoxyspergualin and its lack of cross-resistance to other antitumor agents.
Antitumor activities of 15-deoxyspergualin (NKT-01), an analogue of spergualin (SGL), were examined in cultured tumor cells… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 3
Is this relevant?
1991
1991
The nature of in vivo cell-killing of deoxyspergualin, and its implication in combination with other antitumor agents.
The mode of in vivo cell-killing by 15-deoxyspergualin (NKT-01) was assessed by measuring change of whole body radioactivity of… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
1991
1991
Treatment schedule dependency of antitumor effect of deoxyspergualin.
The effect of treatment schedule on antitumor activity of 15-deoxyspergualin (NKT-01) against P388 leukemia was studied by… (More)
Is this relevant?
1991
1991
Cytostatic Effect of Deoxyspergualin on a Murine Leukemia Cell Line L1210
The mode of antiproliferative action of deoxyspergualin (NKT-01) was examined. The growth-inhibitory effect on a murine leukemia… (More)
Is this relevant?
1990
1990
Deoxyspergualin directly suppresses antibody formation in vivo and in vitro.
The effect of deoxyspergualin (DSG, NKT-01) on humoral immunity was investigated both in vitro and in vivo. DSG inhibited the… (More)
Is this relevant?
1990
1990
Deoxyspergualin therapy in autoimmune MRL/1pr mice suffering advanced lupus-like disease.
The present study was designed to evaluate the therapeutic activity of a novel immunosuppressive agent, deoxyspergualin (DSG, NKT… (More)
  • figure 1
  • figure 2
  • figure 4
  • table 1
  • figure 5
Is this relevant?
1988
1988
Reversal of acute rejection episodes by deoxyspergualin (NKT-01) in dogs receiving renal allografts.
the preventive effect of NKT-01on the rejection of renal allografts in dogs, and suggested that NKT-01 maybe useful in clinical… (More)
  • figure 1
  • figure 2
Is this relevant?
1988
1988
In vivo effects of deoxyspergualin (NKT-01) on lymphocyte activation in response to alloantigens.
We studied the effects of deoxyspergualin (NKT-01) on the events of lymphocyte activation in vivo by inoculating mice in the… (More)
  • table 2
  • figure 1
  • figure 2
Is this relevant?
1988
1988
Biological activities of deoxyspergualin in autoimmune disease mice.
An assessment of the prophylactic and ameliorative effects of deoxyspergualin (NKT-01), an immunosuppressive agent, was carried… (More)
Is this relevant?